Trial Profile
An open labeled, single dose, multiple escalation phase I/II study to evaluate the safety, tolerability and enhancement of tumor detection radiologically using VRP-1620 in patients with solid tumors.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs VRP 1620 (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Venus Remedies
- 07 Feb 2014 New trial record